A New Palliative Care Tool: Psilocybin Assisted Therapy

Submitted By: margo@northcoasteolcollective.com – Click to email about this post
Date: May 16th from 12-1:00 pm (PST)
Offering: A New Palliative Care Tool: Psilocybin Assisted Therapy
Location: Virtual (Zoom)
Registration (required) www.northcoasteolcollective.com/events-one/a-new-palliative-care-tool-psilocybin-assisted-therapy
Presenter: Kathryn L. Tucker, JD, Special Advocacy Advisor – National Psychedelics Association

Description:
Modern-era clinical trials show psilocybin-assisted therapy brings “immediate, substantial and sustained” relief from anxiety and depression in patients with advanced cancer. Palliative care providers are eager to add a new palliative care tool to their toolbox to address non-physical suffering. This presentation will briefly review the trials and findings, the prohibited status of psilocybin under current law, and efforts to evolve the law to allow access for therapeutic purposes. The discussion will include Oregon’s pioneering Psilocybin Services Act, the first state law to legalize and regulate this substance despite its federal status.

Recommended Reading:

IN SEARCH OF: A FEDERAL SAFE HARBOR FOR STATE LEGALIZATION OF PSILOCYBIN, Kathryn L. Tucker, et al.

law.lclark.edu/live/files/34282-264-5-tucker

Presenter Bio:
Kathryn L. Tucker is recognized as a national leader in spearheading creative and effective efforts to promote improved care for seriously ill and dying patients. She has served as Director of Advocacy at various nonprofit organizations, including the National Psychedelics Association, the Completed Life Initiative, the End of Life Liberty Project, the Disability Rights Legal Center, Compassion & Choices, and Compassion in Dying. Tucker was a founding member of the Psychedelic Bar Association and Co-Chair of the Litigation and Advocacy Committee. She is a Founding Member of the Initiative on Psychedelics and Healing of the Global Wellness Institute. In periods of private practice, Tucker served as Special Counsel at Emerge Law Group, where she Co-Chaired the Psychedelic Practice Group, and as a litigation attorney at Perkins Coie (Seattle Office). Tucker has held faculty appointments as Associate Professor of Law at Loyola Law School, Los Angeles, and as Adjunct Professor of Law at the University of Washington, Seattle University, and Lewis & Clark Schools of Law, teaching in the areas of law, medicine, and ethics, with a focus on the end of life. Tucker is counsel in the nation’s first litigation under the Right to Try Act, representing a palliative care physician and several cancer patients seeking to compel DEA to allow access to psilocybin therapy. She is also involved with a first-of-its-kind petition to reschedule psilocybin and related litigation. AIMS et al. v DEA.